CL2015003145A1 - Nuevo uso de clorhidrato de landiolol en el tratamiento a largo plazo de taquiarritmias - Google Patents
Nuevo uso de clorhidrato de landiolol en el tratamiento a largo plazo de taquiarritmiasInfo
- Publication number
- CL2015003145A1 CL2015003145A1 CL2015003145A CL2015003145A CL2015003145A1 CL 2015003145 A1 CL2015003145 A1 CL 2015003145A1 CL 2015003145 A CL2015003145 A CL 2015003145A CL 2015003145 A CL2015003145 A CL 2015003145A CL 2015003145 A1 CL2015003145 A1 CL 2015003145A1
- Authority
- CL
- Chile
- Prior art keywords
- tachyarrhythmias
- long
- term treatment
- new use
- landiolol hydrochloride
- Prior art date
Links
- WMDSZGFJQKSLLH-RBBKRZOGSA-N landiolol Chemical compound O1C(C)(C)OC[C@H]1COC(=O)CCC(C=C1)=CC=C1OC[C@@H](O)CNCCNC(=O)N1CCOCC1 WMDSZGFJQKSLLH-RBBKRZOGSA-N 0.000 title abstract 2
- 229950005241 landiolol Drugs 0.000 title abstract 2
- 208000001871 Tachycardia Diseases 0.000 title 1
- 238000011866 long-term treatment Methods 0.000 title 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
COMPOSICION DE CLORHIDRATO DE LANDIOLOL UTIL PARA REDUCIR LA FRECUENCIA CARDIACA Y/O PRESION SANGUINEA EN TAQUICARDIA SUPRAVENTRICULAR, TAQUIARRITMIA Y/O HIPERTENSION.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13165582.1A EP2796139A1 (en) | 2013-04-26 | 2013-04-26 | Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2015003145A1 true CL2015003145A1 (es) | 2016-06-24 |
Family
ID=48226997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2015003145A CL2015003145A1 (es) | 2013-04-26 | 2015-10-26 | Nuevo uso de clorhidrato de landiolol en el tratamiento a largo plazo de taquiarritmias |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US10722516B2 (es) |
| EP (2) | EP2796139A1 (es) |
| JP (1) | JP2016517860A (es) |
| KR (1) | KR102268161B1 (es) |
| CN (1) | CN105324118A (es) |
| AU (1) | AU2014259352B2 (es) |
| BR (1) | BR112015027051A2 (es) |
| CA (1) | CA2910066C (es) |
| CL (1) | CL2015003145A1 (es) |
| DK (1) | DK2988750T3 (es) |
| EA (1) | EA030589B1 (es) |
| ES (1) | ES2906551T3 (es) |
| HK (1) | HK1214511A1 (es) |
| HR (1) | HRP20220470T1 (es) |
| HU (1) | HUE058189T2 (es) |
| IL (1) | IL242220B (es) |
| LT (1) | LT2988750T (es) |
| MX (1) | MX379191B (es) |
| NZ (1) | NZ713295A (es) |
| PH (1) | PH12015502465A1 (es) |
| PL (1) | PL2988750T3 (es) |
| PT (1) | PT2988750T (es) |
| SG (1) | SG11201508824RA (es) |
| SI (1) | SI2988750T1 (es) |
| TN (1) | TN2015000480A1 (es) |
| UA (1) | UA117243C2 (es) |
| WO (1) | WO2014174076A1 (es) |
| ZA (1) | ZA201508050B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2796139A1 (en) | 2013-04-26 | 2014-10-29 | AOP Orphan Pharmaceuticals AG | Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias |
| CN114031601B (zh) * | 2022-01-12 | 2022-03-18 | 南京桦冠生物技术有限公司 | 一种盐酸兰地洛尔的制备方法 |
| WO2025024637A1 (en) * | 2023-07-25 | 2025-01-30 | Atai Therapeutics, Inc. | Compositions for limiting sympathomimetic effects of psychedelic therapeutics |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004323370A (ja) | 2003-04-22 | 2004-11-18 | Ono Pharmaceut Co Ltd | 麻酔薬と塩酸ランジオロールとを組み合わせてなる併用剤 |
| US20060286037A1 (en) | 2003-08-08 | 2006-12-21 | Ono Pharmaceutical Co., Ltd. | Heart-slowing drug containing short-acting ß blocker as the active ingredient |
| JP4784037B2 (ja) | 2003-08-27 | 2011-09-28 | 独立行政法人国立がん研究センター | 塩酸ランジオロールを含有する頻脈性不整脈の治療剤 |
| CN1827109A (zh) | 2006-04-14 | 2006-09-06 | 北京润德康医药技术有限公司 | 一种以兰洛地尔及其盐为活性成分的冻干粉针制剂及其制备工艺 |
| WO2009079679A2 (de) | 2007-12-21 | 2009-07-02 | Aop Orphan Pharmaceuticals Ag | Pharmazeutische zusammensetzung |
| CN101732319B (zh) | 2008-11-26 | 2012-11-07 | 天津市汉康医药生物技术有限公司 | 含有盐酸兰地洛尔活性成分的注射用药物组合物及其制备方法 |
| CN102232930B (zh) | 2010-05-06 | 2013-03-27 | 南京海辰药业有限公司 | 盐酸兰地洛尔药物组合物及其制备方法 |
| JP2010248263A (ja) | 2010-08-04 | 2010-11-04 | National Cancer Center | 塩酸ランジオロールを含有する頻脈性不整脈の治療剤 |
| CN102475706A (zh) | 2010-11-28 | 2012-05-30 | 天津市汉康医药生物技术有限公司 | 一种供注射用盐酸兰地洛尔药物组合物及其制备方法 |
| EP2796139A1 (en) | 2013-04-26 | 2014-10-29 | AOP Orphan Pharmaceuticals AG | Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias |
-
2013
- 2013-04-26 EP EP13165582.1A patent/EP2796139A1/en not_active Withdrawn
-
2014
- 2014-04-25 HU HUE14720107A patent/HUE058189T2/hu unknown
- 2014-04-25 DK DK14720107.3T patent/DK2988750T3/da active
- 2014-04-25 NZ NZ713295A patent/NZ713295A/en unknown
- 2014-04-25 EP EP14720107.3A patent/EP2988750B1/en active Active
- 2014-04-25 JP JP2016509488A patent/JP2016517860A/ja active Pending
- 2014-04-25 AU AU2014259352A patent/AU2014259352B2/en active Active
- 2014-04-25 TN TN2015000480A patent/TN2015000480A1/en unknown
- 2014-04-25 UA UAA201511610A patent/UA117243C2/uk unknown
- 2014-04-25 MX MX2015014939A patent/MX379191B/es unknown
- 2014-04-25 SI SI201431953T patent/SI2988750T1/sl unknown
- 2014-04-25 LT LTEPPCT/EP2014/058456T patent/LT2988750T/lt unknown
- 2014-04-25 EA EA201592058A patent/EA030589B1/ru not_active IP Right Cessation
- 2014-04-25 PT PT147201073T patent/PT2988750T/pt unknown
- 2014-04-25 PL PL14720107T patent/PL2988750T3/pl unknown
- 2014-04-25 CA CA2910066A patent/CA2910066C/en active Active
- 2014-04-25 US US14/787,217 patent/US10722516B2/en active Active
- 2014-04-25 HR HRP20220470TT patent/HRP20220470T1/hr unknown
- 2014-04-25 KR KR1020157031952A patent/KR102268161B1/ko active Active
- 2014-04-25 BR BR112015027051A patent/BR112015027051A2/pt not_active Application Discontinuation
- 2014-04-25 WO PCT/EP2014/058456 patent/WO2014174076A1/en active Application Filing
- 2014-04-25 SG SG11201508824RA patent/SG11201508824RA/en unknown
- 2014-04-25 CN CN201480033912.7A patent/CN105324118A/zh active Pending
- 2014-04-25 ES ES14720107T patent/ES2906551T3/es active Active
-
2015
- 2015-10-22 IL IL242220A patent/IL242220B/en active IP Right Grant
- 2015-10-26 PH PH12015502465A patent/PH12015502465A1/en unknown
- 2015-10-26 CL CL2015003145A patent/CL2015003145A1/es unknown
- 2015-10-29 ZA ZA2015/08050A patent/ZA201508050B/en unknown
-
2016
- 2016-03-03 HK HK16102471.6A patent/HK1214511A1/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124729T1 (el) | Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου | |
| CY1121153T1 (el) | Παραγωγα εξενδινης-4 ως διπλοι glp1/gιp- ή τριγωνικοι αγωνιστες glp1/gιp/γλυκαγονης | |
| CL2015001358A1 (es) | Potenciadores del cftr deuterados | |
| CL2015000829A1 (es) | Inhibidores de histona desmetilasas | |
| ZA201505813B (en) | Biologically active molecules, conjugates thereof, and therapeutic uses | |
| CY1119518T1 (el) | Τροποποιημενα αντιγονα φυματιωσης | |
| CL2016001231A1 (es) | Compuestos de inhibidor de autotaxina | |
| SG11201811697SA (en) | Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof | |
| EA201491009A1 (ru) | Гель лизата тромбоцитов | |
| PH12015500115A1 (en) | Glucagon analogues | |
| HUE043540T2 (hu) | Szubsztituált dimer kinazolin-származék, elõállítása, valamint alkalmazása 1-es és 2-es típusú cukorbetegség kezelésére szolgáló gyógyászati készítményekben | |
| CL2016000117A1 (es) | Autotaxina inhibidores comprende un anillo heteroaromático-bencilamina ciclo basico | |
| EA201500934A1 (ru) | Кардио- и нефропротективная противодиабетическая терапия | |
| CL2015000294A1 (es) | Combinaciones farmaceuticas que comprenden un inhibidor de b-raf, un inhibidor del receptor del factor de crecimiento epidermico y opcionalmente un inhibidor pi3halpha y uso en el tratamiento de una enfermedad proliferativa. | |
| CL2015002835A1 (es) | Nuevos derivados de piridina | |
| LT2013018A (lt) | Farmacinė kompozicija, skirta gydyti diabetą ir metabolinius sutrikimus | |
| EA201790410A1 (ru) | Содержащая цинеол композиция для назального применения | |
| MX2017012596A (es) | Una composicion farmaceutica y el uso de la misma. | |
| BR112014025416A2 (pt) | AGENTES ANTIMALÁRICOS, COMPOSIÇÃO FARMACEUTICA COMPREENDENDO-OS E USO Dos MESMOS. | |
| CL2015003145A1 (es) | Nuevo uso de clorhidrato de landiolol en el tratamiento a largo plazo de taquiarritmias | |
| EA201591123A1 (ru) | Комбинации агониста glp1r и метформина, а также способ их применения при лечении диабета 2 типа и прочих расстройств | |
| BR112019001130A2 (pt) | uso de lactama e composição farmacêutica | |
| CL2013002322A1 (es) | Uso de una composicion que comprende fentanilo, un intensificador de la penetracion y un liquido volatirl para preparar un medicamenti util en el tratamiento del dolor. | |
| NZ598124A (en) | Compounds for treatment of inflammation | |
| UA115307C2 (uk) | Застосування лікарського засобу, що містить рекомбінантний лектин омели для лікування раку шкіри |